Abstract | BACKGROUND: METHODS: RESULTS: A total of 192 hospitalizations with atrial tachyarrhythmias occurred in 158 patients during a follow-up period of 34 months. The time to first hospitalization with atrial tachyarrhythmias or death was significantly lower in the enalapril group (P =.005). In a multivariate analysis adjusting for the presence of atrial fibrillation at study entry, enalapril treatment was associated with a reduction in the rate of hospitalization with atrial tachyarrhythmias or death (RR, 0.87; 95% CI, 0.79-0.96; P =.007). The incidence of hospitalization with atrial tachyarrhythmias was 7.9 hospitalizations per 1000 patient-years of follow-up in the enalapril group, compared with 12.4 per 1000 patient-years in the placebo group (RR, 0.64; 95% CI, 0.48-0.85; P =.002). CONCLUSION:
|
Authors | Alawi A Alsheikh-Ali, Paul J Wang, William Rand, Marvin A Konstam, Munther K Homoud, Mark S Link, N A Mark Estes 3rd, Deeb N Salem, Amin M Al-Ahmad |
Journal | American heart journal
(Am Heart J)
Vol. 147
Issue 6
Pg. 1061-5
(Jun 2004)
ISSN: 1097-6744 [Electronic] United States |
PMID | 15199356
(Publication Type: Journal Article)
|
Chemical References |
- Angiotensin-Converting Enzyme Inhibitors
- Enalapril
|
Topics |
- Angiotensin-Converting Enzyme Inhibitors
(therapeutic use)
- Atrial Fibrillation
(epidemiology, prevention & control)
- Comorbidity
- Enalapril
(therapeutic use)
- Female
- Follow-Up Studies
- Hospitalization
(statistics & numerical data)
- Humans
- Incidence
- Male
- Middle Aged
- Multivariate Analysis
- Randomized Controlled Trials as Topic
- Retrospective Studies
- Survival Rate
- Ventricular Dysfunction, Left
(drug therapy, epidemiology)
|